Vertex Execs Continue Routine 4,500‑Share Sales Amid Stable Share Price Surge
Vertex insider sells 4,500 shares in routine plan‑based trade; market stays bullish on VRTX’s pipeline and earnings outlook.
3 minutes to read
Vertex Pharmaceuticals Inc
Vertex Exec Charles Wagner Executes Dual Buy‑Sell Hedge, Signaling Long‑Term Confidence at Vertex Pharmaceuticals <|constrain|>2026 <|end|>
Vertex insider trade: Charles Wagner’s 10‑b5‑1 buy‑sell reveals confidence in Vertex’s growth and a strategic, rule‑based approach that could boost the stock’s momentum.
4 minutes to read